HEATHER BRUNK: Open Payments
NPI 1922697168 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 15 payments from 12 companies in 2025. Trend: 2023 $1,001 · 2024 $229 · 2025 $544
Food & beverage: $369Education: $175
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Astellas Pharma US Inc | 2 | $111 |
| AstraZeneca Pharmaceuticals LP | 1 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| BeiGene USA, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Menarini Silicon Biosystems, Inc. | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
Products named: OPDIVO, KISQALI, Fabhalta, Onivyde, KEYTRUDA, TEVIMBRA, VRAYLAR, Cellsearch.
Industry payments across OH — which companies pay providers there.
